En Es
Categories

IDS LIMITED

IDS LIMITED

Immunodiagnostic Systems Holdings PLC (IDS) develops, manufactures, and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.
Products Covid-19Summary
Close

Covid-19 IDS LIMITED

Clinical Laboratory

COVID-19 Anitibody Test
TGS COVID-19 IgM

The TGS COVID-19 IgM test is a chemiluminescent two-step sandwich capture immunoassay (CLIA), for use on IDS-iSYS Multi-Discipline Automated System, for determination of specific IgM class antibodies directed against the SARS CoV-2 Nucleocapsid antigens in samples of human serum or plasma (K3-EDTA, Sodium Citrate, Heparin Sodium). The assay with excellent sensitivity and specificity is used as a diagnostic aid when assessing the immunity status of patients related to COVID-19 and is suitable for use with human serum or plasma.
More details

COVID-19 Anitibody Test
TGS COVID-19 IgG

The TGS COVID-19 IgG test is a chemiluminescent two-step sandwich capture immunoassay (CLIA), for use on IDS-iSYS Multi-Discipline Automated System, for QUANTITATIVE determination of specific IgG class antibodies directed against the SARS-CoV-2 Spike and Nucleocapsid antigens in samples of human serum or plasma (K3-EDTA, sodium citrate, sodium heparin). The assay with excellent sensitivity and specificity is used as a diagnostic aid when assessing the immunity status of patients related to COVID-19 and is suitable for use with human serum or plasma.
More details
Close

About IDS LIMITED

Immunodiagnostic Systems Holdings PLC (IDS) develops, manufactures, and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.

Recently updated

Centromere B Assay
Centromere B Test

The Centromere B Test is a chemiluminescent immunoassay (CLIA) for the quantitative determination of the specific IgG antibodies directed against the Centromere B antigen in human samples of serum or plasma (EDTA). Used for diagnosing limited scleroderma and CREST syndrome, the test is compatible with IDS automated systems. It delivers precise results with just 4 µL of sample and a detection range up to 640 AU/mL, enabling robust autoimmune diagnostics with high throughput.
More details

Autoimmune Disorders Screening Assay
ANA Screen

The ANA Screen is a CLIA-based test for qualitative detection of IgG antibodies to nuclear antigens, including dsDNA, Sm, SSA, SSB, Scl-70, Jo-1, and U1-snRNP. Used on IDS automated analyzers, it screens for autoimmune disorders such as SLE and scleroderma. Requiring only 6 µL of serum or EDTA plasma, the test delivers sensitive, reliable autoimmune profiling with minimal sample volume.
More details

anti-Etanercept Assay
LISA-TRACKER anti-Etanercept

LISA-TRACKER anti-Etanercept is an enzyme linked immunoassay (ELISA) for the quantitative determination of anti-Etanercept antibodies in human serum samples to aid in monitoring immunogenic responses to therapy. Compatible with biosimilars and open automation platforms, the test uses 100 µL samples and detects levels between 10–100 ng/mL. Ready-to-use reagents and standardized protocols make it suitable for therapeutic drug monitoring in autoimmune and inflammatory diseases.
More details

Clinical Laboratory

Centromere B Assay
Centromere B Test

The Centromere B Test is a chemiluminescent immunoassay (CLIA) for the quantitative determination of the specific IgG antibodies directed against the Centromere B antigen in human samples of serum or plasma (EDTA). Used for diagnosing limited scleroderma and CREST syndrome, the test is compatible with IDS automated systems. It delivers precise results with just 4 µL of sample and a detection range up to 640 AU/mL, enabling robust autoimmune diagnostics with high throughput.
More details

Autoimmune Disorders Screening Assay
ANA Screen

The ANA Screen is a CLIA-based test for qualitative detection of IgG antibodies to nuclear antigens, including dsDNA, Sm, SSA, SSB, Scl-70, Jo-1, and U1-snRNP. Used on IDS automated analyzers, it screens for autoimmune disorders such as SLE and scleroderma. Requiring only 6 µL of serum or EDTA plasma, the test delivers sensitive, reliable autoimmune profiling with minimal sample volume.
More details

anti-Etanercept Assay
LISA-TRACKER anti-Etanercept

LISA-TRACKER anti-Etanercept is an enzyme linked immunoassay (ELISA) for the quantitative determination of anti-Etanercept antibodies in human serum samples to aid in monitoring immunogenic responses to therapy. Compatible with biosimilars and open automation platforms, the test uses 100 µL samples and detects levels between 10–100 ng/mL. Ready-to-use reagents and standardized protocols make it suitable for therapeutic drug monitoring in autoimmune and inflammatory diseases.
More details

anti-TNFα Assay
ISA-TRACKER Adalimumab

ISA-TRACKER Adalimumab is an enzyme linked immunoassay (ELISA) for the quantitative determination of Adalimumab (anti-TNFα) in human serum samples. Standardized to WHO reference (17/236), it is validated for both the original drug and biosimilars. Ready-to-use reagents and automation-compatible protocols support efficient workflows. Ideal for monitoring therapeutic levels in inflammatory diseases and oncology, it ensures reproducible results with a working range of 0.3–20 μg/mL from 100 µL serum or plasma samples.
More details

C-Terminal Telopeptide ELISA
Urine BETA CrossLaps (CTX-I) ELISA

The Urine BETA CrossLaps (CTX-I) ELISA is a sensitive enzyme-linked immunosorbent assay (ELISA) designed for the quantitative measurement of C-terminal telopeptide (CTX-I) in urine. CTX-I is a marker of bone resorption, making this test valuable for assessing bone metabolism and monitoring conditions like osteoporosis and other bone-related disorders. The test offers accurate and reliable results, helping healthcare professionals evaluate bone health and response to treatments. It is ideal for use in clinical laboratories to monitor bone turnover in patients undergoing therapy for bone diseases.
More details

Anti-Golimumab ELISA
LISA-TRACKER Duo Golimumab

The LISA-TRACKER Duo Golimumab is a highly sensitive diagnostic tool designed for the detection of anti-Golimumab antibodies in patient samples. Using enzyme-linked immunosorbent assay (ELISA) technology, this test provides precise and reliable results to monitor immune responses to Golimumab therapy. It is ideal for use in clinical settings to assess the immunogenicity of Golimumab, commonly used for treating autoimmune diseases such as rheumatoid arthritis. The test is designed for high accuracy, ease of use, and quick results, supporting informed treatment decisions in patients undergoing Golimumab therapy.
More details

Folate ELISA Test
Folate AccuBind ELISA Test System

The Folate AccuBind ELISA Test System is a highly sensitive enzyme-linked immunosorbent assay (ELISA) designed for the quantitative measurement of folate levels in serum or plasma samples. This test provides accurate and reliable results, aiding in the diagnosis of folate deficiency or excess. It is ideal for clinical laboratories and healthcare professionals to assess vitamin B9 status and support the management of related health conditions. The system is easy to use, offering fast results with high sensitivity and specificity, ensuring effective patient care and diagnosis.
More details

Anti-Bevacizumab ELISA
LISA-TRACKER anti-Bevacizumab

The LISA-TRACKER anti-Bevacizumab is a highly sensitive diagnostic tool designed for the detection of anti-Bevacizumab antibodies in patient samples. This test utilizes enzyme-linked immunosorbent assay (ELISA) technology to provide precise and reliable results, helping healthcare professionals monitor immune responses to Bevacizumab therapy. It is ideal for use in clinical settings to assess potential immunogenicity and inform treatment decisions in patients undergoing Bevacizumab-based therapies for cancer and other conditions. The test is designed for high accuracy and ease of use, ensuring timely and informed clinical care.
More details

Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

LISA-TRACKER anti-Secukinumab is an enzyme-linked immunoassay (ELISA) for the quantitative determination of anti-Secukinumab antibodies in human serum. Validated on principle drugs and biosimilars, it comes with ready-to-use reagents and standardized protocols from sample collection to result interpretation.
More details

Anti-Golimumab ELISA
LISA-TRACKER anti-Golimumab

LISA-TRACKER anti-Golimumab is an enzyme-linked immunoassay (ELISA) for the quantitative determination of anti-Golimumab antibodies in human serum samples. Validated on principle drugs and biosimilars, it comes with ready-to-use reagents and standardized protocols from sample collection to result interpretation.
More details

Infliximab Test
LISA-TRACKER Duo Infliximab

LISA-TRACKER Duo Infliximab is an enzyme-linked immunoassay (ELISA) for the quantitative determination of Infliximab (anti-TNFα) and anti-Infliximab antibodies in human serum samples. Validated on principle drugs and biosimilars, it comes with ready-to-use reagents and standardized protocols from sample collection to result interpretation.
More details

Urinary CTX-II Test
Urine CartiLaps (CTX-II) EIA

Urine CartiLaps (CTX-II) EIA is intended for the determination of degradation products of C-terminal telopeptides of Type II collagen in human urine. The test is meant to be used for the quantitative assessment of disease activity (structural damage of articular cartilage) in patients with RA and OA.
More details

CTX-I Urine Test
Urine CrossLaps (CTX-I) EIA

Urine CrossLaps (CTX-I) EIA is intended for the determination of degradation products of C-terminal telopeptides of Type I collagen (CTX-I) in human urine. CTX-I can be used as an indicator of bone resorption status in patients with metabolic bone disease, e.g. hyperparathyroidism, Paget´s disease, osteodystrophy, and those receiving prolonged glucocorticoid therapy.
More details

Vitamin B12 Test
Vitamin B12 AccuBind ELISA Test System

Vitamin B12 AccuBind ELISA Test System is an in vitro diagnostic device intended for the quantitative determination of Vitamin B12 in human serum. The simple and innovative assay design delivers reliable results and is automation-ready.
More details

Anti-Tocilizumab ELISA
LISA-TRACKER anti-Tocilizumab

LISA-TRACKER anti-Tocilizumab is an enzyme-linked immunoassay (ELISA) for the quantitative determination of anti-Tocilizumab antibodies in human serum samples. It comes with ready-to-use reagents and is automation-ready with protocols available on several open-platform ELISA systems.
More details

Anti-Certolizumab ELISA
LISA-TRACKER anti-Certolizumab

LISA-TRACKER anti-Certolizumab is an enzyme-linked immunoassay for the quantitative determination of human anti-Certolizumab pegol antibodies in human serum samples. It comes with ready-to-use reagents and is automation-ready with protocols available on several open-platform ELISA systems.
More details

Cartilage Oligomeric Matrix Protein Assay
IDS Human COMP ELISA

The IDS Human COMP ELISA is intended for the determination of Cartilage Oligomeric Matrix Protein (COMP) in human serum. The results are to be used as an aid in the prognosis and monitoring of cartilage degradation in conditions such as rheumatoid arthritis and osteoarthritis.
More details

17-OH Progesterone Assay
IDS-iSYS 17-OH Progesterone

The IDS-iSYS 17-OH Progesterone assay is an in vitro diagnostic device intended for the quantitative determination of 17-OH Progesterone in human serum or plasma on the IDS-iSYS multi-discipline automated system. The results are to be used as an aid in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries.
More details

Total 25-Hydroxyvitamin D Assay
IDS-25 VitDS

The IDS-25 VitDS is an automated assay for the quantitative determination of total 25-hydroxyvitamin D [25(OH)D] in human serum and plasma on the IDS System. The results are used in conjunction with other clinical and laboratory data to assist the clinician in the assessment of vitamin D sufficiency.
More details

Vitamin D Assay
1,25-Dihydroxy Vitamin D Assay

The IDS-iSYS 1,25-Dihydroxy Vitamin D assay is a complete assay system intended for the purification of 1,25-dihydroxyvitamin D [1,25D] in human serum or plasma by immunopurification followed by quantitative determination on the IDS-iSYS Multi-Discipline Automated System to assess 1,25-dihydroxyvitamin D deficiency associated with renal disease.
More details

25(OH)D Assay
25-Hydroxy Vitamin DS EIA

The 25-Hydroxy Vitamin DS EIA Assay is intended for the quantitative determination of 25-hydroxyvitamin D [25(OH)D] and other hydroxylated metabolites in human serum and plasma. It is a reliable test for monitoring vitamin D therapy, regardless of the supplementation form, and instills confidence in patient results.
More details

Aldosterone Assay
IDS-iSYS Aldosterone

The IDS-iSYS Aldosterone assay is intended for the quantitative determination of Aldosterone in human EDTA plasma on IDS Systems. The results are to be used in conjunction with other clinical and laboratory data to assist in the clinical assessment of hypertension-related syndromes.
More details

Direct Renin Assay
IDS-iSYS Renin

The IDS-iSYS Renin assay is intended for the quantitative determination of Direct Renin in human EDTA plasma on IDS Systems. The results are to be used in conjunction with other clinical and laboratory data to assist the clinician in the assessment of hypertension-related syndromes.
More details

Salivary Cortisol Assay
IDS-iSYS Salivary Cortisol

The IDS-iSYS Salivary Cortisol assay is intended for the quantitative determination of cortisol in human saliva on the IDS-iSYS Multi-Discipline Automated System family. The results are to be used as an aid in the assessment of Cushing’s and other disorders of the hypothalamic pituitary adrenal axis.
More details

Human Bone Resorption Test
Serum CrossLaps (CTX-I) ELISA

The Serum CrossLaps (CTX-I) ELISA is an enzyme immunological test for the quantification of degradation products of C-terminal telopeptides of Type I collagen in human serum and plasma. The assay is intended for in-vitro diagnostic use as an indication of human bone resorption.
More details

Anti-Mitochondrial M2 Antibody Test
AMA (M2)

The AMA (M2) test is a chemiluminescent immunoassay (CLIA) for the quantitative determination of specific IgG antibodies directed against mitochondrial M2 subtype antigen in human samples of serum or plasma (EDTA and Na-Citrate). The CE Marked IVD assay is meant for use on IDS automated analyzers.
More details

Anti Thyroid Peroxidase Immunossay
Anti-TPO

The Anti-TPO test is a chemiluminescent immunoassay (CLIA) for the quantitative determination of specific IgG antibodies directed against Thyroid Peroxidase (TPO) in human samples of serum or plasma (EDTA, Heparin, Na-Citrate). The CE Marked IVD assay is meant for use on IDS automated analyzers.
More details

Salivary Cortisol Assay
IDS-iSYS Salivary Cortisol

The IDS-iSYS salivary cortisol assay is intended for the quantitative determination of cortisol in human saliva on the IDS-iSYS Multi-Discipline Automated System family. The results are to be used as an aid in the assessment of Cushing’s and other disorders of the hypothalamic pituitary adrenal axis.
More details

Herpes Simplex Virus CLIA
HSV 1 IgG

The HSV 1 IgG test is a chemiluminescent immunoassay (CLIA), for use on IDS automated analyzers, for quantitative determination of specific IgG class antibodies directed against the Herpes Simplex Virus type 1 (HSV 1) in samples of human serum or plasma (K3-EDTA, Sodium Citrate). This assay is used as a diagnostic aid when assessing HSV 1 infections.
More details

Rubella Virus CLIA
Rubella IgM

The Rubella IgM test is a two-step capture chemiluminescent immunoassay (CLIA), for use on IDS automated analyzers, for quantitative determination of specific IgM class antibodies directed against the Rubella virus in samples of human serum or plasma (K3-EDTA, Sodium Citrate). The assay is used as a diagnostic aid when assessing immunity status of patients related to Rubella virus infection.
More details

Automated Total IgE Assay
Total IgE

Total IgE is an automated assay for the quantitative determination of total IgE in human serum on the IDS System. The results are to be used as an aid in the diagnosis and management of allergic disorders in conjunction with other clinical findings.
More details

Liver Kidney Microsomes CLIA Test
LKM-1

The LKM-1 (Liver Kidney Microsomes type 1) test is a chemiluminescent immunoassay (CLIA), for use on IDS automated analyzers. It is used for the quantitative determination of specific IgG class antibodies directed against Liver Kidney Microsomes type 1, in human samples of serum or plasma (EDTA and Sodium Citrate).
More details

Anti-Thyroglobulin Test
Anti-TG

The Anti-TG test is a chemiluminescent immunoassay (CLIA), for use on IDS automated analyzers. It is used for the quantitative determination of the specific IgG antibodies directed against thyroglobulin, in human samples of serum or plasma (EDTA, Heparin or Na-Citrate).
More details

Automated CLIA Cortisol Assay
Urinary Cortisol Assay

The IDS Urinary Cortisol assay is a fully automated CLIA assay for the quantitative determination of cortisol in human urine samples. Results are to be used in conjunction with other clinical and laboratory data to assist clinicians in the diagnosis and monitoring of disorders of the adrenal gland.
More details

Borrelia IgG & IgM Assays
Borrelia IgG and IgM Solution

The IDS Borrelia IgG and IDS Borrelia IgM assays use chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG or IgM antibodies to Borrelia burgdorferi sensu lato in human serum or plasma samples on the IDS system. The results are intended to aid in the assessment of immunity status in patients with signs and symptoms consistent with Lyme disease.
More details

COVID-19 Anitibody Test
TGS COVID-19 IgG

The TGS COVID-19 IgG test is a chemiluminescent two-step sandwich capture immunoassay (CLIA), for use on IDS-iSYS Multi-Discipline Automated System, for QUANTITATIVE determination of specific IgG class antibodies directed against the SARS-CoV-2 Spike and Nucleocapsid antigens in samples of human serum or plasma (K3-EDTA, sodium citrate, sodium heparin). The assay with excellent sensitivity and specificity is used as a diagnostic aid when assessing the immunity status of patients related to COVID-19 and is suitable for use with human serum or plasma.
More details

COVID-19 Anitibody Test
TGS COVID-19 IgM

The TGS COVID-19 IgM test is a chemiluminescent two-step sandwich capture immunoassay (CLIA), for use on IDS-iSYS Multi-Discipline Automated System, for determination of specific IgM class antibodies directed against the SARS CoV-2 Nucleocapsid antigens in samples of human serum or plasma (K3-EDTA, Sodium Citrate, Heparin Sodium). The assay with excellent sensitivity and specificity is used as a diagnostic aid when assessing the immunity status of patients related to COVID-19 and is suitable for use with human serum or plasma.
More details

Proteinase 3 Assay
IDS PR3 Immunoassay

The IDS PR3 test is a chemiluminescent immunoassay (CLIA) for use on IDS automated analyzers. It is used for the quantitative determination of the specific IgG antibodies directed against proteinase 3 (PR3), in human samples of serum or plasma (EDTA and Heparin).
More details

hGH Assay
IDS-iSYS hGH Assay

The IDS-iSYS hGH human Growth Hormone (hGH) assay is intended for the quantitative determination of hGH in human serum or plasma on the IDS-iSYS multi-discipline automated system. Its results are to be used in conjunction with other clinical and laboratory data to assist clinicians in the assessment of growth disorders.
More details

Immunoanalyzer
IDS-i10

The IDS-i10 next generation immunoanalyzer comes with faster testing capability and the capacity to connect to laboratory track systems, which can help medical professionals perform automated immunoassays more efficiently than ever. The chemiluminescence-based technology platform is entirely automated and offers continuous loading, as well as random access analysis.
More details

Immunoassay System
IDS-iSYS

The IDS-iSYS multi-discipline automated immunoassay system has a compact, bench-top design and offers full walk-away automation with auto start-up and shut-down. It also offers continuous loading with batch, random, and STAT flexibility, and on-board refrigeration of ready-to-use reagent cartridges.
More details
Copyright © 2000-2025 TradeMed.com. All rights reserved. | Terms And Conditions